| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Dec 12, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 48.8 | -664 | -0.30% | ✓ | $213.6K |
| Nov 12, 2025 | Nov 14, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 46.3 | -996 | -0.44% | ✓ | $347.8K |
| Oct 8, 2025 | Oct 10, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 32.5 | -10,671 | -4.32% | ✓ | $3.7M |
| Sep 10, 2025 | Sep 12, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 32.5 | -10,006 | -3.96% | ✓ | $3.3M |
| Aug 13, 2025 | Aug 15, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 32.5 | -11,013 | -4.15% | ✓ | $3.3M |
| Jul 30, 2025 | Jul 31, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 45.0 | -920 | -0.34% | ✗ | $280.2K |
| Jun 16, 2025 | Jun 18, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 47.5 | -422 | -0.15% | ✗ | $112.5K |
| Jun 6, 2025 | Jun 10, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 47.5 | -700 | -0.29% | ✗ | $179.3K |
| Feb 27, 2025 | Mar 3, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 45.0 | -1,205 | -0.58% | ✓ | $331.4K |
| Feb 21, 2025 | Feb 25, 2025 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 45.0 | -1,202 | -0.54% | ✓ | $310.2K |
| Sep 30, 2024 | Oct 2, 2024 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 45.0 | -1,202 | -0.50% | ✓ | $285K |
| Jul 30, 2024 | Aug 1, 2024 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 47.5 | -834 | -0.33% | ✗ | $133.9K |
| Jun 17, 2024 | Jun 20, 2024 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 47.5 | -439 | -0.17% | ✗ | $70K |
| Jul 31, 2023 | Aug 2, 2023 | BeOne Medicines Ltd. | SVP, General Counsel | Sell | 47.5 | -791 | -0.46% | ✗ | $171.1K |